Maxi Investments CY Ltd Buys Shares of 77,000 Bath & Body Works, Inc. $BBWI

Maxi Investments CY Ltd bought a new position in Bath & Body Works, Inc. (NYSE:BBWI) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 77,000 shares of the company’s stock, valued at approximately $1,984,000.

Several other institutional investors have also made changes to their positions in the company. Mercer Global Advisors Inc. ADV increased its holdings in Bath & Body Works by 31.4% in the third quarter. Mercer Global Advisors Inc. ADV now owns 116,222 shares of the company’s stock worth $2,994,000 after buying an additional 27,777 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Bath & Body Works during the third quarter valued at about $173,000. Integrated Wealth Concepts LLC lifted its position in shares of Bath & Body Works by 13.4% in the third quarter. Integrated Wealth Concepts LLC now owns 10,788 shares of the company’s stock worth $278,000 after buying an additional 1,278 shares during the last quarter. Gotham Asset Management LLC boosted its stake in shares of Bath & Body Works by 1.4% during the 3rd quarter. Gotham Asset Management LLC now owns 951,370 shares of the company’s stock worth $24,507,000 after acquiring an additional 12,700 shares in the last quarter. Finally, Focus Partners Wealth increased its holdings in shares of Bath & Body Works by 24.3% during the 3rd quarter. Focus Partners Wealth now owns 24,300 shares of the company’s stock valued at $635,000 after acquiring an additional 4,748 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Trading Up 4.8%

Shares of BBWI stock opened at $20.44 on Tuesday. The firm has a market capitalization of $4.18 billion, a P/E ratio of 6.49, a price-to-earnings-growth ratio of 1.95 and a beta of 1.48. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $34.66. The firm’s fifty day simple moving average is $22.37 and its 200 day simple moving average is $22.98.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share for the quarter, beating analysts’ consensus estimates of $1.77 by $0.28. The firm had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.59 billion. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The business’s revenue was down 2.3% on a year-over-year basis. During the same period in the prior year, the firm earned $2.09 EPS. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities research analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 6th. Investors of record on Friday, February 20th were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, February 20th. This represents a $0.80 dividend on an annualized basis and a yield of 3.9%. Bath & Body Works’s dividend payout ratio (DPR) is 25.40%.

Analysts Set New Price Targets

Several brokerages have commented on BBWI. Jefferies Financial Group assumed coverage on Bath & Body Works in a report on Wednesday, January 14th. They set a “hold” rating and a $24.00 price target on the stock. Zacks Research raised shares of Bath & Body Works from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 20th. Citigroup cut shares of Bath & Body Works from a “buy” rating to a “neutral” rating and upped their price target for the company from $21.00 to $25.00 in a report on Tuesday, February 17th. Robert W. Baird set a $20.00 price target on Bath & Body Works in a research report on Wednesday, December 17th. Finally, Telsey Advisory Group lifted their price objective on Bath & Body Works from $23.00 to $25.00 and gave the stock a “market perform” rating in a research note on Thursday, March 5th. Three investment analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $24.00.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.